Tatsuya Tamaoki

7.4k total citations · 2 hit papers
66 papers, 6.6k citations indexed

About

Tatsuya Tamaoki is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Tatsuya Tamaoki has authored 66 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Tatsuya Tamaoki's work include Microbial Natural Products and Biosynthesis (17 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (10 papers). Tatsuya Tamaoki is often cited by papers focused on Microbial Natural Products and Biosynthesis (17 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (10 papers). Tatsuya Tamaoki collaborates with scholars based in Japan, Singapore and United States. Tatsuya Tamaoki's co-authors include Makoto Morimoto, ISAMI TAKAHASHI, Fusao Tomita, Hirofumi Nakano, Yuzuru Kato, Eiji Kobayashi, Hirofumi Nakano, Shiro Akinaga, Eiji Kobayashi and Masami Okabe and has published in prestigious journals such as Blood, Nature Biotechnology and Analytical Biochemistry.

In The Last Decade

Tatsuya Tamaoki

66 papers receiving 6.4k citations

Hit Papers

Staurosporine, a potent i... 1986 2026 1999 2012 1986 1989 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
    1986 2.3k citations Tatsuya Tamaoki, ISAMI TAKAHASHI et al. Biochemical and Biophysical Research Communications profile →
  2. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C
    1989 1.1k citations Eiji Kobayashi, Hirofumi Nakano et al. Biochemical and Biophysical Research Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsuya Tamaoki Japan 31 4.3k 926 749 719 714 66 6.6k
Makoto Morimoto Japan 22 3.3k 0.8× 664 0.7× 843 1.1× 472 0.7× 670 0.9× 71 5.1k
ISAMI TAKAHASHI Japan 19 3.2k 0.7× 605 0.7× 711 0.9× 519 0.7× 499 0.7× 29 4.6k
Yves Gareau Canada 26 3.5k 0.8× 803 0.9× 1.1k 1.4× 420 0.6× 864 1.2× 49 6.1k
Marc Labelle Canada 23 3.6k 0.8× 819 0.9× 873 1.2× 406 0.6× 919 1.3× 40 6.0k
Michel Gallant Canada 20 3.5k 0.8× 782 0.8× 618 0.8× 399 0.6× 633 0.9× 38 5.5k
Shuji Takahashi Japan 37 3.2k 0.7× 420 0.5× 860 1.1× 438 0.6× 766 1.1× 212 5.4k
Hiroshi Ogawara Japan 24 3.1k 0.7× 1.3k 1.4× 303 0.4× 478 0.7× 609 0.9× 123 6.3k
George P. Livi United States 28 4.5k 1.0× 1.3k 1.4× 535 0.7× 681 0.9× 312 0.4× 51 6.4k
David T. Dudley United States 24 5.6k 1.3× 1.6k 1.7× 402 0.5× 685 1.0× 722 1.0× 39 8.6k
Friedrich Marks Germany 49 4.7k 1.1× 828 0.9× 369 0.5× 1.1k 1.5× 1.5k 2.0× 222 8.1k

Countries citing papers authored by Tatsuya Tamaoki

Since Specialization
Citations

This map shows the geographic impact of Tatsuya Tamaoki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Tamaoki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Tamaoki more than expected).

Fields of papers citing papers by Tatsuya Tamaoki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Tamaoki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Tamaoki. The network helps show where Tatsuya Tamaoki may publish in the future.

Co-authorship network of co-authors of Tatsuya Tamaoki

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Tamaoki. A scholar is included among the top collaborators of Tatsuya Tamaoki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Tamaoki. Tatsuya Tamaoki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanda, Yutaka, Tadashi Ashizawa, Kenji Kawashima, Shun‐ichi Ikeda, & Tatsuya Tamaoki. (2003). Synthesis and antitumor activity of novel C-8 ester derivatives of leinamycin. Bioorganic & Medicinal Chemistry Letters. 13(3). 455–458. 24 indexed citations
2.
Nagata, Hiroyuki, Hiroshi Yano, Soichiro Sato, et al.. (2002). Inhibition of Lymphocyte Kinase Lck and Phosphatidylinositol 3-kinase by a Novel Immunosuppressant, Lymphostin. Bioscience Biotechnology and Biochemistry. 66(3). 501–507. 13 indexed citations
3.
Shirai, Akio, et al.. (2001). KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models. Journal of Dermatological Science. 25(3). 213–218. 11 indexed citations
4.
Shiotsu, Yukimasa, Fumihiko Kanai, Chikara Murakata, et al.. (2000). Chemoprotective effects of KF41399, a derivative of carbazole compounds, on nimustine-induced thrombocytopenia. Blood. 95(12). 3771–3780. 1 indexed citations
5.
6.
Akiyama, Tadakazu, Makiko Shimizu, Tatsuya Tamaoki, et al.. (1999). Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).. PubMed. 59(17). 4406–12. 30 indexed citations
7.
Ashizawa, Tadashi, Kenji Kawashima, Yutaka Kanda, et al.. (1999). Antitumor activity of KF22678, a novel thioester derivative of leinamycin. Anti-Cancer Drugs. 10(9). 829–836. 28 indexed citations
8.
Sugawara, Katsura, et al.. (1998). A Useful Method to Evaluate Bone Resorption Inhibitors, Using Osteoclast-like Multinucleated Cells. Analytical Biochemistry. 255(2). 204–210. 12 indexed citations
9.
Dieckmann, Detlef, Bernhard F. Gibbs, Martin Nitschke, et al.. (1997). Heterogeneity of Signal Transduction Mechanisms in Human Basophils and Human Skin Mast Cells. Neurosignals. 6(1). 1–10. 6 indexed citations
10.
11.
Akinaga, Shiro, Katsushige Gomi, Makoto Morimoto, Tatsuya Tamaoki, & Masami Okabe. (1991). Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.. PubMed. 51(18). 4888–92. 167 indexed citations
12.
Bruns, Robert F., Freeman D. Miller, Ronald L. Merriman, et al.. (1991). Inhibition of protein kinase C by calphostin C is light-dependent. Biochemical and Biophysical Research Communications. 176(1). 288–293. 348 indexed citations
13.
Cui, Cheng‐Bin, Yasuhiro Tezuka, Tohru Kikuchi, et al.. (1990). Constituents of a fern, Davallia mariesii Moore. I. Isolation and structures of davallialactone and a new flavanone glucuronide.. Chemical and Pharmaceutical Bulletin. 38(12). 3218–3225. 82 indexed citations
14.
Kobayashi, Eiji, Katsuhiko Ando, Hirofumi Nakano, & Tatsuya Tamaoki. (1989). UCN-1028A, a novel and specific inhibitor of protein kinase C, from Cladosporium.. The Journal of Antibiotics. 42(1). 153–155. 38 indexed citations
15.
TAKAHASHI, ISAMI, et al.. (1989). Hypericin and pseudohypericin specifically inhibit protein kinase C: Possible relation to their antiretroviral activity. Biochemical and Biophysical Research Communications. 165(3). 1207–1212. 182 indexed citations
16.
Tomita, Fusao, Keiichi Takahashi, & Tatsuya Tamaoki. (1984). Quinocarcin, a novel antitumor antibiotic. 3. Mode of action.. The Journal of Antibiotics. 37(10). 1268–1272. 64 indexed citations
17.
Tamaoki, Tatsuya & Fusao Tomita. (1983). Biosynthesis of tetrocarcin. Incorporation of 14C- and 13C-labeled compounds into tetrocarcin.. The Journal of Antibiotics. 36(5). 595–598. 22 indexed citations
18.
Tamaoki, Tatsuya & Fusao Tomita. (1982). Biosynthesis and Production of Tetrocarcin A, a New Antitumor Antibiotic in Chemically Defined Medium. Agricultural and Biological Chemistry. 46(4). 1021–1026. 1 indexed citations
19.
Tamaoki, Tatsuya, Masaji Kasai, Kunikatsu Shirahata, & Fusao Tomita. (1982). Tetrocarcins E1,E2,F and F-1, new antibiotics. Fermentation, isolation and characterization.. The Journal of Antibiotics. 35(8). 979–984. 42 indexed citations
20.
Tomita, Fusao & Tatsuya Tamaoki. (1980). Tetrocarcins, novel antitumor antibiotics. I. Producing organism, fermentation and antimicrobial activity.. The Journal of Antibiotics. 33(9). 940–945. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Morimoto Breakdown of academic impact, for papers by ISAMI TAKAHASHI Breakdown of academic impact, for papers by Yves Gareau Breakdown of academic impact, for papers by Marc Labelle Breakdown of academic impact, for papers by Michel Gallant Breakdown of academic impact, for papers by Shuji Takahashi Breakdown of academic impact, for papers by Hiroshi Ogawara Breakdown of academic impact, for papers by George P. Livi Breakdown of academic impact, for papers by David T. Dudley Breakdown of academic impact, for papers by Friedrich Marks
Rankless by CCL
2026